The MyWay programme gives patients additional support when taking DUPIXENT
The range of services provided are entirely optional and aim to provide assistance to healthcare teams managing the treatment of patients through:
Homecare nurse visits to train patients on self-administration
Support calls and
Reminders for injections,
deliveries and nurse visits
Digital starter kits for adults, adolescents and children, to provide them with the correct tools so they can start their DUPIXENT journey.
Patient information guides
QR codes to access the on-the-go microsites
Virtual reality (VR) glasses
Comics and wallcharts
Parent or carer information guide
Immune micropilots game
EZTrack for Atopic Dermatitis is a free mobile app allowing patients to monitor, track, and manage their AD.
Create photo libraries which track the evolution of lesions over time
Tips and advice on AD and its management
DLQI and POEM assessments to help log itchiness severity, sleep disturbance and potential triggers
Develop report summaries to help navigate productive conversations
Learn more about the Patient Support Programme
- DUPIXENT Summary of Product Characteristics. September 2021.
- Guttman-Yassky E, et al. J Allergy Clin Immunol. 2019;143:155–172.
- Gandhi NA, et al. Nat Rev Drug Discov. 2016;15:35–50.
- D’Erme A, et al. Drug Des Devel Ther. 2017;11:1473–1480.
- McCormick M, et al. Cytokine. 2015;75(1):38–50.
AD, atopic dermatitis; γC, gamma C subunit; IL, interleukin; IL-4Rα; Interleukin 4 receptor alpha; IL-13Rα1, interleukin 13 receptor alpha 1; ILC, innate lymphoid cells; JAK, Janus kinase;
Th, T-helper cells; TYK2, tyrosine kinase 2.
MAT-IE-2101040(v4.0) | Date of preparation: February 2022